SpectronRx
South Bend, Indiana, United States
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (9)
○ EMA GMP
○ MHRA GMP
Quick Facts: SpectronRx
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- South Bend, Indiana, United States
- Website
- https://www.spectronrx.com/home/contract_manufacturing/
- Modalities
- Radiopharmaceuticals
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About SpectronRx
SpectronRx is a contract development and manufacturing organization (CDMO). Capabilities: Radiopharmaceuticals. 3 manufacturing sites registered with the U.S. FDA. Website: https://www.spectronrx.com/home/contract_manufacturing/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Company Signals 9 articles
Company announcements, not verified evidence. They do not change any score.
Telix unveils radiopharmaceutical spinoff Rhine Pharma following string of nuclear medicine acquisitions - Fierce Pharma
SpectronRx Receives Nuclear Materials License for New Indiana Facility - Contract Pharma
CDMO SpectronRx homes in on completion of European plant to crank out key radiopharma isotope - Fierce Pharma
SpectronRx’s New Medical Isotope Production Facility Produces Actinium-225 - Contract Pharma
SpectronRx to Showcase New Facility for the Global Supply of Actinium-225 at SNMMI 2022 - Business Wire
$85M Funding Drives SpectronRx’s Radiopharmaceutical Expansion - Medical Device and Diagnostic industry
SpectronRx raises $85 million to expand isotope production and manufacturing capacity - DOTmed
Drug substance maker raises prices due to energy crisis; SpectronRX gets $85M - Endpoints News
SpectronRx closes on $85M investment for further growth in Miami County - Inside INdiana Business
Frequently Asked Questions About SpectronRx
Does SpectronRx have a CDMO Signal Score?
Not yet. SpectronRx is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating SpectronRx for a manufacturing program?
Use the free AI matchmaker to compare SpectronRx against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Evergreen Theragnostics
Springfield, New Jersey, United States
Radiopharmaceuticals
NorthStar Medical Radioisotopes
Beloit, Wisconsin, United States
Radiopharmaceuticals
Agilera Pharma
Norway (registered site)
Radiopharmaceuticals
ABX advanced biochemical compounds
Germany
Radiopharmaceuticals
AtomVie Global Radiopharma
Canada
Radiopharmaceuticals
Compare SpectronRx with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.